Perampanel-associated self-harm ideation after dosage increase. (Record no. 27779586)

MARC details
000 -LEADER
fixed length control field 01405 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517184234.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201809s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1432-1041
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s00228-017-2348-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kheloufi, Farid
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180914
245 00 - TITLE STATEMENT
Title Perampanel-associated self-harm ideation after dosage increase.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of clinical pharmacology
Date of publication, distribution, etc. Feb 2018
300 ## - PHYSICAL DESCRIPTION
Extent 243-244 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anticonvulsants
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carbamazepine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistant Epilepsy
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epilepsies, Partial
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epilepsy, Tonic-Clonic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nitriles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxcarbazepine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridones
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Self Mutilation
General subdivision chemically induced
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Default, Anne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Perrouty, Bruno
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Blin, Olivier
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Micallef, Joëlle
773 0# - HOST ITEM ENTRY
Title European journal of clinical pharmacology
Related parts vol. 74
-- no. 2
-- p. 243-244
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s00228-017-2348-6">https://doi.org/10.1007/s00228-017-2348-6</a>
Public note Available from publisher's website

No items available.